SYNACT PHARMA ApS — Credit Rating and Financial Key Figures
CVR number: 34459975
Dronninggårds Alle 136, 2840 Holte
joo@txppharma.com
tel: 28447567
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -16 674.00 | -43 429.98 | -46 951.48 | -63 448.35 | -26 274.87 |
| Employee benefit expenses | -2 647.44 | -7 454.00 | -6 409.70 | -8 310.37 | |
| Total depreciation | - 287.00 | - 472.09 | - 816.86 | -1 011.14 | -1 449.43 |
| EBIT | -16 961.00 | -46 549.51 | -55 222.33 | -70 869.19 | -36 034.67 |
| Other financial income | 4.00 | 0.08 | 221.84 | 53.61 | 166.39 |
| Other financial expenses | - 424.00 | - 108.82 | - 279.81 | -93.34 | - 109.10 |
| Pre-tax profit | -17 381.00 | -46 658.26 | -55 280.30 | -70 908.93 | -35 977.38 |
| Income taxes | 3 379.00 | 5 501.63 | 5 500.00 | 5 500.00 | 5 500.00 |
| Net earnings | -14 002.00 | -41 156.63 | -49 780.30 | -65 408.93 | -30 477.38 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 1 485.00 | 3 090.18 | 4 626.17 | 6 291.49 | 7 856.95 |
| Intangible assets total | 1 485.00 | 3 090.18 | 4 626.17 | 6 291.49 | 7 856.95 |
| Machinery and equipment | 3.00 | ||||
| Tangible assets total | 3.00 | ||||
| Investments total | 158.00 | 199.49 | 180.31 | 93.49 | 93.49 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 11 616.60 | ||||
| Current amounts owed by group member comp. | 127.00 | ||||
| Current owed by particip. interest comp. | 483.57 | ||||
| Prepayments and accrued income | 107.00 | 203.31 | 46.02 | 67.06 | 11 522.02 |
| Current other receivables | 981.00 | 1 631.68 | 2 828.29 | 2 694.16 | 3 502.56 |
| Current deferred tax assets | 3 378.00 | 5 500.00 | 5 500.00 | 5 500.00 | 5 500.00 |
| Short term receivables total | 4 593.00 | 7 334.99 | 19 990.92 | 8 261.23 | 21 008.15 |
| Cash and bank deposits | 6 452.00 | 2 919.44 | 13 149.75 | 12 138.68 | 8 833.48 |
| Cash and cash equivalents | 6 452.00 | 2 919.44 | 13 149.75 | 12 138.68 | 8 833.48 |
| Balance sheet total (assets) | 12 691.00 | 13 544.10 | 37 947.15 | 26 784.89 | 37 792.08 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 | 1 000.00 |
| Share premium account | 17 060.00 | 17 060.00 | |||
| Asset revaluation reserve | 83 635.02 | 160 761.18 | |||
| Retained earnings | 24 360.00 | -53 889.36 | -95 045.99 | 79 994.89 | 54 585.96 |
| Profit of the financial year | -14 002.00 | -41 156.63 | -49 780.30 | -65 408.93 | -30 477.38 |
| Shareholders equity total | 11 358.00 | 6 649.03 | 33 994.89 | 15 585.96 | 25 108.59 |
| Provisions | 100.00 | 4 027.09 | 1 356.97 | ||
| Non-current liabilities total | |||||
| Current trade creditors | 1 333.00 | 5 363.01 | 2 439.60 | 6 062.02 | 10 766.61 |
| Current owed to group member | 1.02 | ||||
| Other non-interest bearing current liabilities | 1 531.04 | 1 412.67 | 1 109.82 | 559.92 | |
| Current liabilities total | 1 333.00 | 6 895.07 | 3 852.26 | 7 171.84 | 11 326.52 |
| Balance sheet total (liabilities) | 12 691.00 | 13 544.10 | 37 947.15 | 26 784.89 | 37 792.08 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.